Researchers say study findings have highlighted biomarkers that could help improve early diagnosis of esophageal cancer, when it is easier to treat.

HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.

Perfusion is nothing new in bioprocess engineering, according to Jacobtorweihe, but oncolytic viruses can be more challenging for manufacturers using continuous processes because they can have a ...

Progeria, an ultrarare and fatal genetic disease characterized by rapid aging, can affect children and young adults.

Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...

Seal’s Will Moss explains why chain-of-identity failures threaten patient safety and cell and gene therapy scale-up.

Fully automated “self-driving” process development labs are an attractive idea, but human expertise and oversight will always be needed.

Theravance Biopharma said it is chopping its workforce by 50% and launching a review of strategic alternatives designed to maximize shareholder value, after its sole rare disease pipeline candidate, ...

Hydration energetics may become a central tool in engineering safer, longer-circulating, and more effective nanoparticle therapies.

To support drug discovery, a new study has revealed fundamental features of the transcription cycle in the bacteria that causes tuberculosis.

ShunzymeX addresses inherent challenges in traditional microbial downstream purification due to microbial-expressed protein diversity.

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...